PrEP Watch is a clearinghouse for PrEP data, research, cost, access, implementation and advocacy efforts across the globe.
Countries are at varying stages of introducing daily oral PrEP using TDF/FTC, which is now recommended by WHO as an option for people at substantial risk of HIV. Some countries have national programs; others have smaller-scale programs; others aren’t offering PrEP at all.
In this map, yellow countries have some form of PrEP programming; blue countries do not. Check back for regular updates!
This framework outlines the steps in this process for PrEP programs to have an impact and provides links to specific tools and resources for the following steps.
August 6, 2018
Pilot PrEP projects have been underway in some African countries for several years. But it has only been since late 2017 that some countries have started serious PrEP availability programmes for wider populations.
July 24, 2018
Not a single gay man who took two HIV prevention pills before and after sex had contracted HIV within a year thereafter, new research has found.
June 30, 2018
Public health officials are expanding efforts to get the HIV prevention pill into the hands of those at risk, in a nationwide effort to curb infections. But the officials are hitting roadblocks — the drug's price tag, which has surged in recent years, and changes in insurance coverage that put a heftier financial burden on patients.
May 15, 2018
The US Food and Drug Administration has expanded the approval of Truvada as pre-exposure prophylaxis (PrEP) against HIV to include adolescents. Truvada was approved as an HIV prevention method in 2012 but only for individuals age 18 and older. The new approval expands this indication to include adults and adolescents at risk for HIV.